Edition:
India

Cocrystal Pharma Inc (COCP.OQ)

COCP.OQ on NASDAQ Stock Exchange Capital Market

3.86USD
18 Jan 2019
Change (% chg)

$0.03 (+0.78%)
Prev Close
$3.83
Open
$3.79
Day's High
$3.90
Day's Low
$3.79
Volume
1,654
Avg. Vol
12,294
52-wk High
$6.43
52-wk Low
$1.51

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.062
Jun '18 0.00 -0.048
Mar '18 0.00 -0.064
FY 2017 Dec '17 0.00 0.212
Sep '17 0.00 -0.093
Jun '17 0.00 -0.041
Mar '17 0.00 -0.107
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Earnings (per share)
Quarter Ending Mar-19 1 -0.08 -0.08 -0.08 --
Quarter Ending Jun-19 1 -0.08 -0.08 -0.08 --
Year Ending Dec-19 1 -0.35 -0.35 -0.35 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.48 33.71
P/E High - Last 5 Yrs. -- 45.02 49.93
P/E Low - Last 5 Yrs. -- 23.66 24.27
Beta 1.93 0.90 0.90
Price to Sales (TTM) -- 4.12 6.28
Price to Book (MRQ) 1.74 5.11 5.27
Price to Tangible Book (MRQ) -- 5.85 6.79
Price to Cash Flow (TTM) -- 24.01 24.84
% Owned Institutions 0.01 0.91 1.69

Dividends

  Company industry sector
Dividend Yield -- 1.49 1.40
Dividend Yield - 5 Year Avg -- 1.51 1.42
Dividend 5 Year Growth Rate -- 4.13 4.83
Payout Ratio(TTM) -- 43.96 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 4.30 9.72
Sales (TTM) vs TTM 1 Yr. Ago -100.00 4.14 5.87
Sales - 5 Yr. Growth Rate -- 10.87 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 69.87 45.04 47.26
EPS (TTM) vs TTM 1 Yr. Ago -80.95 -- --
EPS - 5 Yr. Growth Rate -- 10.28 10.82
Capital Spending - 5 Yr. Growth Rate -38.41 15.84 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.26
Current Ratio (MRQ) 2.74 2.98 3.08
LT Debt to Equity (MRQ) 0.00 8.86 11.38
Total Debt to Equity (MRQ) 0.00 12.90 16.13
Interest Coverage (TTM) -- 33.85 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 53.65 53.78
Gross Margin - 5 Yr. Avg. -- 51.65 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -196,820.59 17.95 12.87
Operating Margin (TTM) -- 14.28 6.20
Operating Margin - 5 Yr. Avg. -201,893.70 14.22 8.31
Pre-Tax Margin (TTM) -- 14.84 7.17
Pre-Tax Margin - 5 Yr. Avg. -208,399.09 14.67 8.61
Net Profit Margin (TTM) -- 11.08 3.30
Net Profit Margin - 5 Yr. Avg. -157,026.70 11.02 4.88
Effective Tax Rate (TTM) -- 23.02 22.88
Effective Tax Rate - 5 Yr. Avg. -- 23.17 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 959,798,954 844,239,566
Net Income/Employee (TTM) -3,954,722 113,819,313 100,064,145
Receivable Turnover (TTM) -- 5.72 5.72
Inventory Turnover (TTM) -- 2.61 3.48
Asset Turnover (TTM) 0.00 0.97 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -41.33 11.55 11.08
Return on Assets - 5 Yr. Avg. -24.46 12.93 12.21
Return on Investment (TTM) -41.96 14.98 14.48
Return on Investment - 5 Yr. Avg. -25.93 16.85 15.88
Return on Equity (TTM) -52.95 16.31 15.99
Return on Equity - 5 Yr. Avg. -64.56 17.77 17.00
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % -33.45 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cocrystal Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 8.23%
# of Holders: 32
Total Shares Held: 2,462,436
3 Mo. Net Change: 11,326
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 0
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.